Poor old Antipodes - hated by everyone it seems

Antipodes Global (ASX:APL)

Bella Kidman: Okay. Chris, I'm crossing my fingers that I've got one for you here. Our final underperformer for today is Antipodes Global. They're trading at a 9.5% discount to NTA. But surprisingly, the share price is up around 19% over the last 12 months. Buy, hold or sell?

Chris Brycki (SELL): This was probably not the right one to hang your hat on hoping that I'll give my recommendation for it, Bella. It's another sell. In fact, it's probably one of the higher conviction sells, I would say. It's had horrible performance of about 4% a year over the last three years. Huge underperformance versus the index, 1.1% fees and a 15% performance fee. Avoid.

Bella Kidman: James, everyone loves a discount. We all like to see that we're getting a good deal. Is Antipodes Global a good deal? Buy, hold or sell?

James Whelan (SELL): I think it's a discount for a reason there, Bella. It's a sell for me as well. I don't really see what they do that's superstar amazing or different from anything. If I invest in a LIC I like it to be for a real reason because there's some out-performance, or some benefits, or some sort of strategic advantage. I don't really see that they've got it, and it's going to have to be a sell from me.